Market Closed -
Bombay S.E.
11:00:51 21/05/2024 BST
|
5-day change
|
1st Jan Change
|
197.1
INR
|
-1.20%
|
|
-2.30%
|
-7.12%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,118
|
2,571
|
940.7
|
4,326
|
17,328
|
10,535
|
Enterprise Value (EV)
1 |
4,855
|
3,769
|
1,928
|
4,267
|
17,274
|
12,979
|
P/E ratio
|
17.1
x
|
12
x
|
4.57
x
|
6.93
x
|
21.4
x
|
23.3
x
|
Yield
|
1.05%
|
1.28%
|
3.49%
|
1.08%
|
0.57%
|
0.25%
|
Capitalization / Revenue
|
0.51
x
|
0.38
x
|
0.15
x
|
0.56
x
|
1.57
x
|
0.89
x
|
EV / Revenue
|
0.79
x
|
0.56
x
|
0.31
x
|
0.56
x
|
1.57
x
|
1.1
x
|
EV / EBITDA
|
7.04
x
|
4.51
x
|
2.81
x
|
3.27
x
|
11.5
x
|
14.8
x
|
EV / FCF
|
-20.8
x
|
7.77
x
|
8.63
x
|
4.87
x
|
-31.3
x
|
-4.71
x
|
FCF Yield
|
-4.8%
|
12.9%
|
11.6%
|
20.6%
|
-3.19%
|
-21.2%
|
Price to Book
|
1.14
x
|
0.88
x
|
0.31
x
|
1.18
x
|
3.41
x
|
1.83
x
|
Nbr of stocks (in thousands)
|
56,300
|
56,300
|
56,300
|
56,300
|
59,200
|
62,371
|
Reference price
2 |
55.37
|
45.67
|
16.71
|
76.83
|
292.7
|
168.9
|
Announcement Date
|
22/05/18
|
02/09/19
|
26/08/20
|
25/08/21
|
05/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,152
|
6,739
|
6,208
|
7,660
|
11,007
|
11,797
|
EBITDA
1 |
690
|
836.5
|
686.1
|
1,304
|
1,497
|
874.9
|
EBIT
1 |
325.1
|
393.1
|
378.6
|
981.7
|
1,177
|
592.6
|
Operating Margin
|
5.29%
|
5.83%
|
6.1%
|
12.82%
|
10.69%
|
5.02%
|
Earnings before Tax (EBT)
1 |
235.4
|
270.2
|
274.2
|
935
|
1,148
|
602
|
Net income
1 |
182.4
|
214.3
|
205.8
|
624.6
|
852.5
|
451.8
|
Net margin
|
2.97%
|
3.18%
|
3.32%
|
8.15%
|
7.74%
|
3.83%
|
EPS
2 |
3.240
|
3.806
|
3.656
|
11.09
|
13.67
|
7.242
|
Free Cash Flow
1 |
-233
|
484.8
|
223.5
|
877
|
-551.7
|
-2,755
|
FCF margin
|
-3.79%
|
7.19%
|
3.6%
|
11.45%
|
-5.01%
|
-23.35%
|
FCF Conversion (EBITDA)
|
-
|
57.96%
|
32.58%
|
67.25%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
226.28%
|
108.58%
|
140.42%
|
-
|
-
|
Dividend per Share
2 |
0.5833
|
0.5833
|
0.5833
|
0.8333
|
1.667
|
0.4167
|
Announcement Date
|
22/05/18
|
02/09/19
|
26/08/20
|
25/08/21
|
05/09/22
|
04/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,737
|
1,198
|
987
|
-
|
-
|
2,443
|
Net Cash position
1 |
-
|
-
|
-
|
58.8
|
54.7
|
-
|
Leverage (Debt/EBITDA)
|
2.518
x
|
1.432
x
|
1.439
x
|
-
|
-
|
2.792
x
|
Free Cash Flow
1 |
-233
|
485
|
224
|
877
|
-552
|
-2,755
|
ROE (net income / shareholders' equity)
|
6.86%
|
7.6%
|
6.91%
|
18.6%
|
18.7%
|
8.14%
|
ROA (Net income/ Total Assets)
|
4.04%
|
4.94%
|
5.04%
|
12.9%
|
11.2%
|
4.21%
|
Assets
1 |
4,514
|
4,338
|
4,086
|
4,853
|
7,597
|
10,745
|
Book Value Per Share
2 |
48.50
|
51.60
|
54.20
|
64.90
|
85.80
|
92.20
|
Cash Flow per Share
2 |
0.5100
|
4.470
|
0.4300
|
3.180
|
18.10
|
0.8300
|
Capex
1 |
404
|
237
|
174
|
147
|
1,170
|
2,543
|
Capex / Sales
|
6.57%
|
3.52%
|
2.81%
|
1.91%
|
10.63%
|
21.55%
|
Announcement Date
|
22/05/18
|
02/09/19
|
26/08/20
|
25/08/21
|
05/09/22
|
04/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.12% | 149M | | +18.32% | 67.02B | | +3.36% | 49.69B | | +19.83% | 42.41B | | +23.39% | 26.65B | | +12.19% | 19.62B | | +0.75% | 17.1B | | +3.32% | 15.64B | | -24.51% | 15.43B | | -9.92% | 15.3B |
Other Specialty Chemicals
|